ES2062435T3 - Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales. - Google Patents

Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales.

Info

Publication number
ES2062435T3
ES2062435T3 ES90401019T ES90401019T ES2062435T3 ES 2062435 T3 ES2062435 T3 ES 2062435T3 ES 90401019 T ES90401019 T ES 90401019T ES 90401019 T ES90401019 T ES 90401019T ES 2062435 T3 ES2062435 T3 ES 2062435T3
Authority
ES
Spain
Prior art keywords
oxazolines
amino
aryloximetil
salts
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90401019T
Other languages
English (en)
Inventor
Patrick Descas
Emmanuel Residence Bea Panconi
Christian Jarry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma SAS
Original Assignee
Laboratoires Sarget
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Sarget filed Critical Laboratoires Sarget
Application granted granted Critical
Publication of ES2062435T3 publication Critical patent/ES2062435T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A AMINO-2-ARILOXIMETIL-5-OXAZOLINAS DE ESTRUCTURA: (FIG.A), DONDE EL GRUPO ARIL ES UN FENIL-2-FENILO, UN FENIL-3-FENILO O UN FENIL-4-FENILO. LOS COMPUESTOS DE LA INVENCION SON UTILES COMO MEDICAMENTO.
ES90401019T 1989-04-14 1990-04-12 Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales. Expired - Lifetime ES2062435T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8905180A FR2645860B1 (fr) 1989-04-14 1989-04-14 Nouvelles aryloxymethyl-5 amino-2 oxazolines, syntheses et applications therapeutiques

Publications (1)

Publication Number Publication Date
ES2062435T3 true ES2062435T3 (es) 1994-12-16

Family

ID=9380895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90401019T Expired - Lifetime ES2062435T3 (es) 1989-04-14 1990-04-12 Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales.

Country Status (10)

Country Link
US (1) US5081137A (es)
EP (1) EP0392929B1 (es)
JP (1) JPH0327367A (es)
AT (1) ATE100090T1 (es)
CA (1) CA2014232A1 (es)
DE (1) DE69005876T2 (es)
DK (1) DK0392929T3 (es)
ES (1) ES2062435T3 (es)
FR (1) FR2645860B1 (es)
PT (1) PT93722A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726558B1 (fr) * 1994-11-03 1996-12-06 Adir Nouvelles 5-(aryloxymethyl) oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101174191B1 (ko) 2007-02-02 2012-08-14 에프. 호프만-라 로슈 아게 중추 신경계 장애의 치료용 ｔａａｒ1 리간드로서 2-아미노옥사졸린
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
WO2017157873A1 (en) 2016-03-17 2017-09-21 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL48823C (es) * 1937-01-14
US2181085A (en) * 1938-08-17 1939-11-21 Dow Chemical Co Ether
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3818028A (en) * 1972-11-01 1974-06-18 Dow Chemical Co Substituted-5-(2,4,6-trihalophenoxy)-methyl)-2-oxazoline compounds
PT77428B (fr) * 1982-10-05 1986-02-27 Cortial Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant

Also Published As

Publication number Publication date
EP0392929A1 (fr) 1990-10-17
US5081137A (en) 1992-01-14
EP0392929B1 (fr) 1994-01-12
FR2645860A1 (fr) 1990-10-19
PT93722A (pt) 1990-11-20
CA2014232A1 (fr) 1990-10-14
DE69005876T2 (de) 1994-06-16
DE69005876D1 (de) 1994-02-24
JPH0327367A (ja) 1991-02-05
DK0392929T3 (da) 1994-04-11
ATE100090T1 (de) 1994-01-15
FR2645860B1 (fr) 1991-07-26

Similar Documents

Publication Publication Date Title
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2036551T3 (es) Compuestos heterociclicos.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2071351T3 (es) Un procedimiento para la produccion de 6,12-dihidro-6-hidroxicannabidiol y el uso del mismo para la produccion de trans-delta-9-tetrahidrocannabinol.
ES2021027T5 (es) Un procedimiento para producir un compuesto de piridinsulfonamida sustituido.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2029842T3 (es) Procedimiento para preparar un derivado de quinolina.
FR2377392A1 (fr) Nouveaux medicaments derives de la meta-trifluoromethyl-phenylpiperazine
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
PT99961A (pt) Processo para a preparacao de novos analogos de estatona difluorados com accao antiviral
ES2062435T3 (es) Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
AR217432A1 (es) Nuevas 2,4,6-trihalo-n-alquilo(c1-c2)-2',4',6'-trinitrodifenilaminas con actividad rodenticida
ES2052009T3 (es) Compuestos ciclicos que contienen azufre.
FR2376846A1 (fr) Nouveaux derives de la piperidine
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
ES2036178T3 (es) Procedimiento para preparar nuevas benzamidas.
IT7829921A0 (it) Procedimento per la produzione dell'antibiotico ottenuto coltivando un microorganismo del genere nocardia
ES2113851T3 (es) Sales cristalinas estables y muy hidrosolubles antivirales de 2',3'-didesoxiinoxina monohidrato, 2',3'-didesoxi-2',3'-didehidrotimidina monohidrato y 2',3'-didesoxi-2'-fluoroinosina hemihidrato.
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.
ES2063007T3 (es) Composiciones farmaceuticas que contienen trapidil, y procedimiento para su preparacion.
ES2043778T3 (es) Procedimiento para preparar oxiindanos y tetrahidronaftalenos herbicidas.
AR248137A1 (es) Procedimiento para la preparacion de 4-alquil-1, 4-dihidropiridinas con actividad paf-antagonista.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 392929

Country of ref document: ES